Effect of Iv Hboc-201 on Coronary Hemodynomlcs and Function in Patients Undergoing Elective Pci
作者单位：COR-001 Study Group Biopure CorporationCambridgeMA 02141U.S.A.
会议名称：《第十一届国际人工血液大会》
会议日期：1000年
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
摘 要：正Hemoglobin based oxygen carriers（HBOCs）are potential therapeutic adjuncts to patients with acute coronary syndrome undergoing elective percutaneous coronary intervention（PCI）. Feasibility of intravenous（Ⅳ）HBOC-201 therapy in this patient population was *** a double blinded phase Ⅱ pilot trial,